Excel Industries LtdQ1 FY25Chemicals & Petrochemicals

Excel Industries Ltd

Q1 FY25 Earnings Call Analysis

Management growth scorecard

Revenue

Category 3

Margin

Category 3

Fundraise

N/A

Order

N/A

Capex

Yes

1 of 3 growth signals are positive — mixed outlook.

Revenue guidance

Category 3

→FY '25 revenue grew 18% YoY to approx. Rs 978 crores, driven largely by volume growth with some price benefit.
→Normal monsoon forecast for India in FY '26 expected to support a normal agrochemical sector year.
→Biocides capacity expansion to be completed by H2 FY '26, potentially providing incremental revenue.
→Focus on both spot market and strategic product positioning over order book approach.
→Plans to spend Rs 200-300 crores CAPEX over 3 years to support growth, including new product launches and capacity expansion.
→Continued emphasis on specialty chemicals alongside agrochemicals to diversify revenue mix.
→Aim to improve capacity utilization from current 70-75%, with peak possible at 85-90%.
→Growth CAPEX expected to target specialty chemicals and adjacent product opportunities.
→Anticipation of steady or improving EBITDA margins (13-15%) aligning with growth.

Category 3

→Excel Industries targets EBITDA margins of 13% to 15% over the medium term, aiming for a resilient and sustainable business model with operational efficiencies and improved product mix.
→FY '25 saw an 18% revenue growth to Rs 978 crores and a strong EBITDA increase of 400%, indicating positive momentum.
→Future CAPEX of Rs 200 to 300 crores over 3 years focuses on growth opportunities, especially in specialty chemicals and existing/adjacent products, supported by a strong balance sheet and internal accruals.
→Capacity utilization currently at 70%-75%, with a peak effective utilization of 85%-90% before new CAPEX required, supporting scalable growth.
→Volume growth is expected to drive revenue increases alongside new product launches, including biocides and contract manufacturing opportunities.
→The company plans to maintain a balanced approach to growth with both maintenance and growth CAPEX for sustained profitability and earnings expansion.

Get access to all 5 sections — revenue, margin, fundraise, orderbook, and capex — for Excel Industries Ltd and 1,400+ other companies.

→No specific mention of new fundraising through debt or equity was made during the call.
→The Company currently has a strong balance sheet.
→Support for planned investments and CAPEX (Rs. 200-300 crores over 3 years) is planned to be largely funded through internal accruals.
→No disclosure of new borrowings or equity issuance was indicated at this time.
→Any future requirements or disclosures related to fundraising will be communicated as necessary.

→Excel Industries does not follow a traditional order book approach; instead, they focus on a mix of spot market opportunities and positioning for key products.
→The company sees good demand for certain biocides and has already expanded capacity in this segment.
→They are working on a range of new biocide products to expand this portfolio.
→The company anticipates a normal agrochemical sector year in FY '26, supported by forecasts of a normal monsoon in India.
→Due to volatile market conditions, Excel prefers to maintain flexibility rather than relying on a fixed order book.
→No specific disclosures were made about pending orders or order backlog, reflecting a focus on real-time market dynamics rather than long-term order commitments.

Yes

→Excel Industries plans to spend Rs. 200 to Rs. 300 crores of CAPEX over the next 3 years covering maintenance, modernization, and growth initiatives.
→Annual maintenance and modernization CAPEX is typically Rs. 40 to Rs. 50 crores.
→Growth CAPEX will focus on both new product opportunities and strengthening existing product lines, with an emphasis on specialty chemicals.
→Rs. 15 crores is allocated for setting up an R&D center for process development and technology innovation.
→Asset turnover for future growth CAPEX is expected in the range of 1.25 to 1.5 times.
→Internal accruals will largely support these investments, backed by a strong balance sheet.
→Capacity expansions include doubling capacity for certain biocides and increasing agrochemical production capabilities.

How does Excel Industries Ltd rank vs peers in Chemicals & Petrochemicals?

Pro feature

1Excel Industries Ltd

Rev 3Mar 3

See full Chemicals & Petrochemicals sector rankings

Want more stocks like Excel Industries Ltd?

Build an AI portfolio filtered by sector, market cap, and growth rank. Takes 2 minutes.